Cita APA (7a ed.)

Ackermann, M., Kempf, H., Hetzel, M., Hesse, C., Hashtchin, A. R., Brinkert, K., . . . Lachmann, N. (2018). Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections. Nature Portfolio.

Cita Chicago Style (17a ed.)

Ackermann, Mania, et al. Bioreactor-based Mass Production of Human IPSC-derived Macrophages Enables Immunotherapies Against Bacterial Airway Infections. Nature Portfolio, 2018.

Cita MLA (8a ed.)

Ackermann, Mania, et al. Bioreactor-based Mass Production of Human IPSC-derived Macrophages Enables Immunotherapies Against Bacterial Airway Infections. Nature Portfolio, 2018.